While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...

Tobacco seller Philip Morris International (PM) recently soared to new heights on the back of its blockbuster Q4 2024 ...

Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

Philip Morris International (NYSE:PM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” ...

Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...

Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...

Philip Morris International is the world’s largest tobacco company by volume, with cigarette sales to roughly 170 countries. Despite such dominance, its goal is to completely replace its cigarette ...

Phillip Morris International has reported strong duty-free revenue growth in the company’s 2024 financial results, with the numbers buoyed by a surge in demand for smoke-free products.